Biomira (BRA-T) Stock Predictions - Stockchase
WATCH LIST
18
Biomira (BRA-T)

ON STOCKCHASE SINCE Oct 2000

Breast cancer applications

biotechnology/pharmaceutical

Biomira

BRA-T

0 watching          
Join the Discussion

Biomira (BRA-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about BRA-T



  • All
  • Filtered
Signal Opinion Expert
SELL
Biomira(BRA-T) 

December 3, 2004

Not a fan of biotech stocks. Difficult to read with all the little points of approval or non-approval. With the big spike, don't buy.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Not a fan of biotech stocks. Difficult to read with all the little points of approval or non-approval. With the big spike, don't buy.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Chapman

Investment, Union Securities Ltd...

Price Price
$3.880
Owned Owned
No

TOP PICK
Biomira(BRA-T) 

April 23, 2004

The entire energy sector is an interesting play. There has been a shrinkage of capacity in the last several years.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
The entire energy sector is an interesting play. There has been a shrinkage of capacity in the last several years.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Alison Deans

Chief Inve, Lehman BrothersPriva...

Price Price
$67.580
Owned Owned
Yes

DON'T BUY
Biomira(BRA-T) 

January 16, 2003

Outlook is anybody's guess. No earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Outlook is anybody's guess. No earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ross Healy

Chairman, Strategic Analysis C...

Price Price
$1.850
Owned Owned
Unknown

DON'T BUY
Biomira(BRA-T) 

January 16, 2002

Will take a while. Prefers Isotechnica,
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Will take a while. Prefers Isotechnica,
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ray Steele

Vice Presi, Mavrix Fund Manageme...

Price Price
$6.280
Owned Owned
Unknown

BUY on WEAKNESS
Biomira(BRA-T) 

December 28, 2001

RISKY. No earnings. Treat as a trading stock between $5 and $7.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
RISKY. No earnings. Treat as a trading stock between $5 and $7.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$6.750
Owned Owned
Unknown

BUY
Biomira(BRA-T) 

November 14, 2001

Good long term investment, but prefers MDS.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Good long term investment, but prefers MDS.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Brieger

Chairman &, GlobeInvestment Capi...

Price Price
$7.000
Owned Owned
Unknown

DON'T BUY
Biomira(BRA-T) 

October 31, 2001

Great product, but company has had problems.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Great product, but company has had problems.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Glenn Paradis,

Vice Presi, Aegon Capital Manage...

Price Price
$6.000
Owned Owned
Unknown

DON'T BUY
Biomira(BRA-T) 

September 19, 2001

Biotechs out of favour. Has broken $6.40. Next level is $3.90.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Biotechs out of favour. Has broken $6.40. Next level is $3.90.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$6.300
Owned Owned
Unknown

WAIT
Biomira(BRA-T) 

May 25, 2001

Taking a long time to get to market.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Taking a long time to get to market.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
John Zechner

Chairman, J. Zechner & Assoc...

Price Price
$12.640
Owned Owned
Unknown

DON'T BUY
Biomira(BRA-T) 

May 18, 2001

Doesn't have top line growth. Some products in 3rd phase. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Doesn't have top line growth. Some products in 3rd phase. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
John Zechner

Chairman, J. Zechner & Assoc...

Price Price
$11.080
Owned Owned
Unknown

BUY on WEAKNESS
Biomira(BRA-T) 

May 4, 2001

In phase 3 and has partnered with Merk.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
In phase 3 and has partnered with Merk.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Glenn Paradis,

Vice Presi, Aegon Capital Manage...

Price Price
$12.960
Owned Owned
Unknown

BUY
Biomira(BRA-T) 

April 9, 2001

Smart mngmnt. Good sector. Big litigation risk re: patents/class action suits in pharmaceuticals.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Smart mngmnt. Good sector. Big litigation risk re: patents/class action suits in pharmaceuticals.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Baskin

President, Baskin Wealth Manage...

Price Price
$10.380
Owned Owned
Unknown

BUY
Biomira(BRA-T) 

February 1, 2001

Good company. Drugs in 3rd phase. Short term should do well. Getting a new partner
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Good company. Drugs in 3rd phase. Short term should do well. Getting a new partner
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Glenn Paradis,

Vice Presi, Aegon Capital Manage...

Price Price
$12.400
Owned Owned
Unknown

BUY on WEAKNESS
Biomira(BRA-T) 

January 23, 2001

A very active/volatile stock. Lots of press
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A very active/volatile stock. Lots of press
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Steven Misener

Portfolio , C.I. Mutual Funds...

Price Price
$12.850
Owned Owned
Unknown

DON'T BUY
Biomira(BRA-T) 

November 21, 2000

Difficult to select which bio company but prefers BioChem or a fund
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Difficult to select which bio company but prefers BioChem or a fund
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Fred Ketchen

Managing D, Scotia McLeod...

Price Price
$13.000
Owned Owned
Unknown

Showing 1 to 15 of 18 entries
Successfully Saved Company
Successfully Saved Company